Auxly Cannabis Group Inc.
TSX:XLY.TODrug Manufacturers - Specialty & Generic
Healthcare
$3.53 +0.00%
+$0.00 today
- Market cap
- $364.42M
- Beta
- 1.16
- P/E (TTM)
- 7.3
- EPS (TTM)
- $0.02
52W Low $0.08High $0.19
Volume 0.13M
Average 0.71M
Cash Flow
Check whether earnings turn into cash.
Operating Cash Flow
$25.89M
FY 2025 · Annual
+54.3% YoYInvesting Cash Flow
-$2.46M
FY 2025 · Annual
Financing Cash Flow
-$9.81M
FY 2025 · Annual
Cash Flow Statement
CAD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (45.91M) | (130.29M) | (44.51M) | (16.35M) | 41.86M |
| Depreciation & Amortization | 14.27M | 21.58M | 11.21M | 10.28M | 11.45M |
| Deferred Income Tax | (4.33M) | (6.26M) | (3.24M) | 15.99M | (9.34M) |
| Stock-Based Compensation | 1.43M | 4.02M | 1.64M | 5.05M | 5.27M |
| Change in Working Capital | (29.66M) | 20.04M | 17.87M | (54K) | (12.68M) |
| Accounts Receivables | (16.65M) | 10.41M | 801K | (5.83M) | 134K |
| Inventory | (6.93M) | (3.22M) | 12.72M | 1.57M | (3.25M) |
| Accounts Payables | 210K | 3.17M | 7.16M | 3.69M | (9.05M) |
| Other Working Capital | (6.28M) | 9.69M | (2.81M) | 515K | (515K) |
| Other Non-Cash Items | 14.56M | 88.43M | 25.25M | 1.87M | (10.67M) |
| Operating Cash Flow | (49.63M) | (2.48M) | 8.21M | 16.78M | 25.89M |
| Capital Expenditures | (378K) | (9.19M) | (1.6M) | (2.76M) | (2.52M) |
| Acquisitions (Net) | 7.47M | 10.3M | 0 | 0 | 54K |
| Purchases of Investments | (900K) | (10.37M) | 0 | 0 | 0 |
| Sales of Investments | 10.24M | 71K | 0 | 100K | 0 |
| Other Investing Activities | 897K | 10.37M | 47K | 2.22M | 0 |
| Investing Cash Flow | 17.33M | 1.18M | (1.56M) | (445K) | (2.46M) |
| Debt Repayment | 29.71M | (6.76M) | (8.39M) | (14.48M) | (8.36M) |
| Common Stock Issued | 44.94M | 7.94M | 3.13M | 1.5M | 976K |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (4.39M) | 7.94M | (431K) | (612K) | (2.42M) |
| Financing Cash Flow | 26.4M | 1.18M | (5.69M) | (13.59M) | (9.81M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | (5.9M) | (118K) | 972K | 2.75M | 13.62M |
| Free Cash Flow | (50.01M) | (11.67M) | 6.61M | 14.02M | 23.37M |
Free Cash Flow
Net Income to FCF bridge
FY2025
= Net Income$41.9M
+ D&A$11.4M
+ Stock-Based Comp$5.3M
- Deferred Tax-$9.3M
- Working Capital-$12.7M
- Other Non-Cash-$10.7M
= Operating Cash Flow$25.9M
- Capex-$2.5M
= Free Cash Flow$23.4M
Analysis
FY2025 free cash flow is $23.4M. FCF conversion is 55.8% of net income. Operating cash flow was $25.9M, with capex of -$2.5M. The largest bridge item is Working Capital at -$12.7M.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
No filings found.
Does XLY.TO generate free cash flow?
Auxly Cannabis Group Inc. (XLY.TO) generated $23.37M of free cash flow in fiscal 2025.
How much operating cash flow does XLY.TO produce?
Operating cash flow was $25.89M, before capital expenditures of $2.52M.
Continue the stock analysis
Jump to another research area for this company.